H-GLEWIGAIYPGNGDTSYNQK-OH

Rif. 3D-PP42018

Informazioni sul prodotto

• Nome: H-GLEWIGAIYPGNGDTSYNQK-OH

Descrizione

Peptide H-GLEWIGAIYPGNGDTSYNQK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLEWIGAIYPGNGDTSYNQK-OH include the following: Validated LC/MS bioanalysis of rituximab CDR peptides using nano-surface and molecular-orientation limited (nSMOL) proteolysis N Iwamoto, M Takanashi, A Hamada - Biological and , 2016 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bpb/39/7/39_b16-00230/_article/-char/ja/ Development of a multidimensional online method for the characterization and quantification of monoclonal antibodies using immobilized flow-through enzyme LMH Reinders, MD Klassen, T Teutenberg - Analytical and , 2021 - Springerhttps://link.springer.com/article/10.1007/s00216-021-03683-z Tracking the behavior of monoclonal antibody product quality attributes using a multi-attribute method workflow C Jakes , S Millan-Martin, S Carillo - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jasms.0c00432 Development, validation, and comparison of two mass spectrometry methods (LC-MS/HRMS and LC-MS/MS) for the quantification of rituximab in human plasma A Millet, N Khoudour, D Lebert, C Machon, B Terrier - Molecules, 2021 - mdpi.comhttps://www.mdpi.com/1420-3049/26/5/1383 Intra-articular delivery of full-length antibodies through the use of an in situ forming depot A Fayd'herbe De Maudave, W Leconet , K Toupet - Journal of Controlled , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365921006611

• Marchio: Biosynth